Susquehanna International Group, LLP Biotechnology

Susquehanna International Group, LLP

  • $688 Billion
  • Q2 2025

Stock List

Stock Option Type Value Options Held Last Trade Trade History
MREO
Mereo Biopharma Group PLC
CALL
$362,000
134K
Q2 2025
Added 107.33%
ARCT
Arcturus Therapeutics Holdings Inc.
PUT
$361,000
27.8K
Q2 2025
Added 113.61%
BMEA
Biomea Fusion, Inc.
CALL
$360,000
200K
Q2 2025
Reduced 66.15%
SANA
Sana Biotechnology, Inc.
PUT
$355,000
130K
Q2 2025
Reduced 20.66%
EYPT
Eye Point Pharmaceuticals, Inc.
CALL
$350,000
37.3K
Q2 2025
Added 89.88%
GMAB
Genmab A/S
PUT
$349,000
16.9K
Q2 2025
New holding
MIRM
Mirum Pharmaceuticals, Inc.
CALL
$346,000
6.8K
Q2 2025
Reduced 7.41%
SGMO
Sangamo Therapeutics, Inc
CALL
$333,000
618K
Q2 2025
Reduced 57.27%
VCEL
Vericel Corp
PUT
$327,000
7.7K
Q2 2025
Reduced 10.33%
PGEN
Precigen, Inc.
CALL
$317,000
224K
Q2 2025
Added 593.0%
SGMO
Sangamo Therapeutics, Inc
PUT
$305,000
566K
Q2 2025
Reduced 57.27%
MREO
Mereo Biopharma Group PLC
PUT
$302,000
112K
Q2 2025
Added 107.33%
MNKD
Mannkind Corp
PUT
$298,000
79.7K
Q2 2025
Reduced 18.58%
ATAI
Atai Life Sciences N.V.
PUT
$296,000
135K
Q4 2024
Added 2204.3%
ADPT
Adaptive Biotechnologies Corp
PUT
$293,000
25.2K
Q2 2025
Added 33.11%
GMAB
Genmab A/S
CALL
$293,000
14.2K
Q2 2025
New holding
SAVA
Cassava Sciences Inc
CALL
$287,000
159K
Q2 2025
Reduced 19.13%
CELC
Celcuity Inc.
PUT
$287,000
21.5K
Q2 2025
Added 48.95%
LEGN
Legend Biotech Corp
CALL
$287,000
8.1K
Q2 2025
Added 148.13%
AKBA
Akebia Therapeutics, Inc.
PUT
$283,000
77.9K
Q2 2025
Added 15.14%
OMER
Omeros Corp
PUT
$257,000
85.9K
Q2 2025
Reduced 46.23%
VERU
Veru Inc.
PUT
$251,000
433K
Q2 2025
Added 25.16%
PLX
Protalix Bio Therapeutics, Inc.
CALL
$248,000
168K
Q2 2025
Reduced 65.23%
EDIT
Editas Medicine, Inc.
PUT
$241,000
110K
Q2 2025
Added 61.34%
AKBA
Akebia Therapeutics, Inc.
CALL
$222,000
61.1K
Q2 2025
Added 15.14%
LIFE
A Tyr Pharma Inc
PUT
$222,000
120K
Q2 2025
Reduced 85.34%
NUVB
Nuvation Bio Inc.
PUT
$221,000
114K
Q2 2025
Added 58.8%
IMNM
Immunome Inc.
CALL
$216,000
23.3K
Q2 2025
Reduced 90.18%
TSHA
Taysha Gene Therapies, Inc.
CALL
$215,000
93.3K
Q2 2025
Reduced 6.55%
XERS
Xeris Biopharma Holdings, Inc.
CALL
$210,000
45.1K
Q2 2025
Reduced 36.31%
ARCT
Arcturus Therapeutics Holdings Inc.
CALL
$208,000
16K
Q2 2025
Added 113.61%
INVA
Innoviva, Inc.
CALL
$206,000
10.3K
Q2 2025
Added 33.33%
EWTX
Edgewise Therapeutics, Inc.
CALL
$204,000
15.6K
Q2 2025
Reduced 34.75%
RGNX
Regenxbio Inc.
PUT
$188,000
22.9K
Q2 2025
Added 8.68%
VIR
Vir Biotechnology, Inc.
CALL
$188,000
37.4K
Q2 2025
Reduced 1.55%
GERN
Geron Corp
CALL
$177,000
126K
Q2 2025
Reduced 14.36%
FULC
Fulcrum Therapeutics, Inc.
PUT
$176,000
25.7K
Q2 2025
Added 53.44%
BMEA
Biomea Fusion, Inc.
PUT
$173,000
96.3K
Q2 2025
Reduced 66.15%
CRVS
Corvus Pharmaceuticals, Inc.
CALL
$170,000
42.6K
Q2 2025
Reduced 92.87%
IMTX
Immatics N.V.
CALL
$169,000
31.5K
Q2 2025
Added 25.68%
ETON
Eton Pharmaceuticals, Inc.
PUT
$168,000
11.8K
Q2 2025
Reduced 93.18%
EDIT
Editas Medicine, Inc.
CALL
$163,000
74.1K
Q2 2025
Added 61.34%
NVCT
Nuvectis Pharma, Inc.
CALL
$162,000
21.8K
Q2 2025
New holding
OCUL
Ocular Therapeutix, Inc
PUT
$162,000
17.5K
Q2 2025
Added 307.02%
GERN
Geron Corp
PUT
$160,000
114K
Q2 2025
Reduced 14.36%
DYN
Dyne Therapeutics, Inc.
PUT
$158,000
16.7K
Q2 2025
Added 20.51%
ADCT
Adc Therapeutics Sa
PUT
$152,000
57K
Q2 2025
Added 11.03%
OCGN
Ocugen, Inc.
PUT
$151,000
156K
Q2 2025
Reduced 51.42%
CSBR
Champions Oncology, Inc.
CALL
$144,000
19.6K
Q2 2025
Reduced 73.18%
Filter Shares Options
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email